[HTML][HTML] Chemotherapy plus erlotinib versus chemotherapy alone for treating advanced non-small cell lung cancer: a meta-analysis
JL Xu, B Jin, ZH Ren, YQ Lou, ZR Zhou, QZ Yang… - PloS one, 2015 - journals.plos.org
Background Whether a combination of chemotherapy and erlotinib is beneficial for
advanced non-small cell lung cancer (NSCLC) remains controversial. This study aimed to …
advanced non-small cell lung cancer (NSCLC) remains controversial. This study aimed to …
[PDF][PDF] Chemotherapy plus Erlotinib versus Chemotherapy Alone for Treating Advanced Non-Small Cell Lung Cancer: A Meta-Analysis
JL Xu, B Jin, ZH Ren, YQ Lou, ZR Zhou, QZ Yang - PLoS ONE, 2015 - researchgate.net
Background Whether a combination of chemotherapy and erlotinib is beneficial for
advanced non-small cell lung cancer (NSCLC) remains controversial. This study aimed to …
advanced non-small cell lung cancer (NSCLC) remains controversial. This study aimed to …
Chemotherapy plus Erlotinib versus Chemotherapy Alone for Treating Advanced Non-Small Cell Lung Cancer: A Meta-Analysis.
JL Xu, B Jin, ZH Ren, YQ Lou, ZR Zhou, QZ Yang… - Plos one, 2015 - europepmc.org
Background Whether a combination of chemotherapy and erlotinib is beneficial for
advanced non-small cell lung cancer (NSCLC) remains controversial. This study aimed to …
advanced non-small cell lung cancer (NSCLC) remains controversial. This study aimed to …
Chemotherapy plus Erlotinib versus Chemotherapy Alone for Treating Advanced Non-Small Cell Lung Cancer: A Meta-Analysis
JL Xu, B Jin, ZH Ren, YQ Lou, ZR Zhou, QZ Yang… - PLOS …, 2015 - econpapers.repec.org
Background: Whether a combination of chemotherapy and erlotinib is beneficial for
advanced non-small cell lung cancer (NSCLC) remains controversial. This study aimed to …
advanced non-small cell lung cancer (NSCLC) remains controversial. This study aimed to …
[PDF][PDF] Chemotherapy plus Erlotinib versus Chemotherapy Alone for Treating Advanced Non-Small Cell Lung Cancer: A Meta-Analysis
JL Xu, B Jin, ZH Ren, YQ Lou, ZR Zhou… - PLoS …, 2015 - pdfs.semanticscholar.org
Background Whether a combination of chemotherapy and erlotinib is beneficial for
advanced non-small cell lung cancer (NSCLC) remains controversial. This study aimed to …
advanced non-small cell lung cancer (NSCLC) remains controversial. This study aimed to …
[引用][C] Chemotherapy plus Erlotinib versus Chemotherapy Alone for Treating Advanced Non-Small Cell Lung Cancer: A Meta-Analysis
JL Xu, B Jin, ZH Ren, YQ Lou, ZR Zhou… - PLoS …, 2015 - ui.adsabs.harvard.edu
Chemotherapy plus Erlotinib versus Chemotherapy Alone for Treating Advanced Non-Small
Cell Lung Cancer: A Meta-Analysis - NASA/ADS Now on home page ads icon ads Enable full …
Cell Lung Cancer: A Meta-Analysis - NASA/ADS Now on home page ads icon ads Enable full …
Chemotherapy plus Erlotinib versus Chemotherapy Alone for Treating Advanced Non-Small Cell Lung Cancer: A Meta-Analysis.
JL Xu, B Jin, ZH Ren, YQ Lou, ZR Zhou… - PLoS …, 2015 - search.ebscohost.com
Background: Whether a combination of chemotherapy and erlotinib is beneficial for
advanced non-small cell lung cancer (NSCLC) remains controversial. This study aimed to …
advanced non-small cell lung cancer (NSCLC) remains controversial. This study aimed to …
Chemotherapy plus Erlotinib versus Chemotherapy Alone for Treating Advanced Non-Small Cell Lung Cancer: A Meta-Analysis
JL Xu, B Jin, ZH Ren, YQ Lou, ZR Zhou… - PloS …, 2015 - pubmed.ncbi.nlm.nih.gov
Background Whether a combination of chemotherapy and erlotinib is beneficial for
advanced non-small cell lung cancer (NSCLC) remains controversial. This study aimed to …
advanced non-small cell lung cancer (NSCLC) remains controversial. This study aimed to …
Chemotherapy plus Erlotinib versus Chemotherapy Alone for Treating Advanced Non-Small Cell Lung Cancer: A Meta-Analysis
JL Xu, B Jin, ZH Ren, YQ Lou, ZR Zhou, QZ Yang… - PLOS ONE, 2015 - ideas.repec.org
Background: Whether a combination of chemotherapy and erlotinib is beneficial for
advanced non-small cell lung cancer (NSCLC) remains controversial. This study aimed to …
advanced non-small cell lung cancer (NSCLC) remains controversial. This study aimed to …
[HTML][HTML] Chemotherapy plus Erlotinib versus Chemotherapy Alone for Treating Advanced Non-Small Cell Lung Cancer: A Meta-Analysis
JL Xu, B Jin, ZH Ren, YQ Lou, ZR Zhou, QZ Yang… - PLoS ONE, 2015 - ncbi.nlm.nih.gov
Background Whether a combination of chemotherapy and erlotinib is beneficial for
advanced non-small cell lung cancer (NSCLC) remains controversial. This study aimed to …
advanced non-small cell lung cancer (NSCLC) remains controversial. This study aimed to …